Carlsmed Stands Out Among Surgical Equipment Peers

Got story updates? Submit your updates here. ›

Carlsmed (NASDAQ:CARL) is a medical technology company pioneering AI-enabled personalized spine surgery solutions. The company's aprevo Technology Platform provides customized surgical plans and implants to optimize patient outcomes and reduce the need for revision surgeries. Carlsmed's approach contrasts with traditional spine fusion surgery, which often lacks robust pre-operative planning and uses one-size-fits-all implants. Carlsmed's technology has shown favorable results in achieving proper post-operative alignment and reducing revision surgery rates compared to traditional methods.

Why it matters

Carlsmed's personalized spine surgery solutions address key limitations of traditional spine fusion procedures, which can lead to poor clinical outcomes and high revision surgery rates. By leveraging AI and customized implants, Carlsmed aims to improve patient health, quality of life, and reduce the economic burden on the healthcare system.

The details

Carlsmed's aprevo Technology Platform utilizes AI-enabled algorithms and 3D modeling to develop personalized digital surgical plans and custom-designed interbody implants for each patient's unique anatomy. This contrasts with traditional spine fusion, which relies on 2D imaging and stock implants that often fail to match patient anatomy. Carlsmed's technology is FDA-cleared for lumbar fusion procedures and the company is developing it for cervical fusion as well. Carlsmed has a growing base of clinical evidence demonstrating improved alignment and reduced revision surgery rates compared to traditional methods.

• Carlsmed received FDA 510(k) clearance for its aprevo interbody implants for cervical interbody fusion surgeries in November 2024.
• Carlsmed plans to commercialize the aprevo Technology Platform for cervical fusion surgery in 2026.

What’s next

Carlsmed plans to continue building out its aprevo Technology Platform for cervical fusion procedures by pursuing additional clearances for advancements to its cervical software platform and personalized plating solutions.